The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Our IP is strong on many levels for both companies as can be seen from searches
Morning,
Am I correct that the Key elements of the detection hardware/software has a number of strong patents attached to it ?
Fully understand; within the fca and AIM /EU Mar guidelines if there is anything can be shared that would be great so as a shareholder we get assured the companies are going towards the right direction! I’m pretty confident current management and board are doing their best so we can see true value reflected in the near future . I am long term s/h on MWG ( bought at 15p, 10p, 8p then recently considering both working together on a product ) and new to Skin, I thought mwg will go bust but now we can see huge potential, just hope it gets crystallised soon !
We do appreciate your efforts and courage to engage with ordinary share holder like us and we trust with your leadership both co will reach it’s true potential! Keep up the good work . Kind regards
@SS17 I must operate under AIM and EU MAR Rules when responding to questions that would be material so can only respond to questions on information that is in the public domain. I trust you understand.
Thanks for sharing this. I have invested in both MWG and Skin, both have huge potential with unique products which are very relevant for current environment and help with the Covid 19. I’m not sure why market is not reflecting fair value, are you able to share , if both are working with any government or potential deals in the pipeline . Once market sees a few good contract both should fly like other Covid shares such as NCYt
Just because I don't answer every question doesn't mean I don't read them. This has been in the public domain since November 2019 in RNS and on the company website. But for your information, the answer is yes.
https://www.labskin.co.uk/rinoclouds-ai-rawtest-a-resounding-success/
I'm not an expert, but I understood Faecal Coliform to be a sort of genus/grouping term used in which certain strain specific Microorganisms can be found. One such subgroup of them is E-Coli l, which we know is covered (and many other subgroups thereof I am sure), by the Labskin/RawTest set-up.
I could be somewhat wrong on the explanation.
Well I guess that's a NO then..
Watching a show on RTE of how important it is to treat superbug antibiotic resistance bacteria..